USANA Health Sciences, Inc. (USNA)
USD 34.62
(-4.58%)
USD 34.62
(-4.58%)
| Breakdown | 2023 | 2022 | 2022 | 2021 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 70.64 Million | 103.9 Million | 121.22 Million | 160.4 Million | 126.73 Million | 152.11 Million |
| Net Income | 63.78 Million | 69.35 Million | 116.5 Million | 124.66 Million | 100.52 Million | 126.22 Million |
| Depreciation & Amortization | 20.39 Million | 21.41 Million | 22.19 Million | 22.5 Million | 23 Million | 16.84 Million |
| Deferred income taxes | -2.74 Million | -7.18 Million | -2.97 Million | -2.42 Million | -3.63 Million | 699 Thousand |
| Stock-based compensation | 14.59 Million | 13.33 Million | 14.29 Million | 14.39 Million | 15.54 Million | 14.95 Million |
| Change in working capital | -27.99 Million | 6.85 Million | -28.86 Million | 556 Thousand | -8.79 Million | -7.74 Million |
| Other non-cash items | 2.61 Million | 141 Thousand | 61 Thousand | 701 Thousand | 84 Thousand | 1.14 Million |
| Investing Cash Flow | -11.97 Million | -12.37 Million | -14.18 Million | -33.96 Million | 47.49 Million | -69 Million |
| Investments in PPE | -14.49 Million | -10.4 Million | -12.76 Million | -15.09 Million | -16.56 Million | -11.43 Million |
| Acquisitions | 15 Thousand | -6.53 Million | -1.93 Million | 6000.00 | 17 Thousand | 381 Thousand |
| Investment purchases | -1.27 Million | - | -1.55 Million | -21.08 Million | -1.66 Million | -86.39 Million |
| Sales/Maturities of investments | 3.77 Million | 4.55 Million | 1.93 Million | 1.93 Million | 65.47 Million | 23.59 Million |
| Other Investing Activities | 2.51 Million | 7000.00 | 131 Thousand | 281 Thousand | 231 Thousand | 4.84 Million |
| Financing Cash Flow | -14.23 Million | -30.08 Million | -181.41 Million | -59.44 Million | -152.05 Million | -105.27 Million |
| Debt repayment | -792 Thousand | -11 Million | - | -60 Million | -5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -11.59 Million | -25.38 Million | -177.83 Million | -57.02 Million | -150 Million | -105.37 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.84 Million | 6.29 Million | -3.57 Million | 57.58 Million | 2.94 Million | 98 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -428 Thousand | -2.65 Million | -4.57 Million | 6.07 Million | 1.83 Million | -1.72 Million |
| Inventory | 2.35 Million | 21.87 Million | -10.5 Million | -16.78 Million | 12.99 Million | -23.1 Million |
| Other working capital | -29.92 Million | -12.37 Million | -13.78 Million | 11.26 Million | -23.61 Million | 17.07 Million |
| Cash at beginning of period | 288.42 Million | 243.65 Million | 315.93 Million | 237.68 Million | 217.23 Million | 250.53 Million |
| Cash at end of period | 330.42 Million | 291.32 Million | 243.65 Million | 315.93 Million | 237.68 Million | 217.23 Million |
| Capital Expenditure | -14.49 Million | -10.4 Million | -12.76 Million | -15.09 Million | -16.56 Million | -11.43 Million |
| Effect of forex changes on cash | -2.5 Million | -13.77 Million | 2.08 Million | 11.25 Million | -1.72 Million | -11.14 Million |
| Net cash flow / Change in cash | 42 Million | 47.66 Million | -72.28 Million | 78.24 Million | 20.45 Million | -33.3 Million |
| Free Cash Flow | 56.14 Million | 93.5 Million | 108.46 Million | 145.3 Million | 110.16 Million | 140.68 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 10.43 Million | 16.53 Million | 16.76 Million | 63.78 Million | 11.34 Million | 17.29 Million |
| Depreciation & Amortization | 5.7 Million | 5.08 Million | 4.87 Million | 20.39 Million | 5.15 Million | 5.14 Million |
| Deferred income taxes | -7.46 Million | 2.54 Million | 1.46 Million | -2.74 Million | 808 Thousand | -8.58 Million |
| Stock-based compensation | 3.73 Million | 3.66 Million | 3.64 Million | 14.59 Million | 3.67 Million | 3.67 Million |
| Change in working capital | -4.6 Million | -11.49 Million | -3.32 Million | -27.99 Million | 1.22 Million | -7.96 Million |
| Other non-cash items | 19.6 Million | -16.53 Million | 2.59 Million | 2.61 Million | 24 Thousand | -12 Thousand |
| Investing Cash Flow | -1.54 Million | -4.06 Million | -7.32 Million | -11.97 Million | -1.45 Million | 179 Thousand |
| Investments in PPE | -2.67 Million | -3.2 Million | -7.32 Million | -14.49 Million | -1.45 Million | -3.6 Million |
| Acquisitions | - | 3000.00 | 2000.00 | 15 Thousand | - | 13 Thousand |
| Investment purchases | - | -870 Thousand | 5.05 Million | -1.27 Million | - | -3.78 Million |
| Sales/Maturities of investments | 1.12 Million | - | - | 3.77 Million | - | 3.77 Million |
| Other Investing Activities | 1.12 Million | -867 Thousand | 2000.00 | 2.51 Million | - | 3.78 Million |
| Financing Cash Flow | -1.35 Million | -11.94 Million | 658 Thousand | -14.23 Million | -11.64 Million | -55 Thousand |
| Debt repayment | -1.32 Million | -537 Thousand | -792 Thousand | -792 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -31 Thousand | -9.44 Million | -134 Thousand | -11.59 Million | -11.59 Million | -55 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -31 Thousand | -3.03 Million | 1.45 Million | -1.84 Million | -42 Thousand | -55 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.59 Million | -1.71 Million | 1.92 Million | -428 Thousand | -1.18 Million | -925 Thousand |
| Inventory | -2.68 Million | -1.8 Million | -1.05 Million | 2.35 Million | 1.26 Million | -72 Thousand |
| Other working capital | -326 Thousand | -7.97 Million | -4.2 Million | -29.92 Million | 1.14 Million | -6.96 Million |
| Cash at beginning of period | 328.33 Million | 333.24 Million | 307.08 Million | 288.42 Million | 300.18 Million | 298.36 Million |
| Cash at end of period | 332.42 Million | 331.1 Million | 330.42 Million | 330.42 Million | 307.08 Million | 302.94 Million |
| Capital Expenditure | -2.67 Million | -3.2 Million | -7.32 Million | -14.49 Million | -1.45 Million | -3.6 Million |
| Effect of forex changes on cash | -1.02 Million | -3.8 Million | 4.06 Million | -2.5 Million | -2.25 Million | -5.1 Million |
| Net cash flow / Change in cash | 4.08 Million | -2.14 Million | 23.33 Million | 42 Million | 6.89 Million | 4.57 Million |
| Free Cash Flow | 5.31 Million | 14.48 Million | 18.69 Million | 56.14 Million | 20.78 Million | 5.94 Million |
0K9L
EYE
NL
1807
7066
STGW